[go: up one dir, main page]

SE8404283L - Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar - Google Patents

Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar

Info

Publication number
SE8404283L
SE8404283L SE8404283A SE8404283A SE8404283L SE 8404283 L SE8404283 L SE 8404283L SE 8404283 A SE8404283 A SE 8404283A SE 8404283 A SE8404283 A SE 8404283A SE 8404283 L SE8404283 L SE 8404283L
Authority
SE
Sweden
Prior art keywords
diagnostic
specific
associated antigen
sialosyllactotetraus
tumorally
Prior art date
Application number
SE8404283A
Other languages
Unknown language ( )
English (en)
Other versions
SE8404283D0 (sv
SE455445B (sv
Inventor
Jan Roland Holmgren
Leif Gustav Lindholm
Lars Torvald Svennerholm
Original Assignee
Jan Roland Holmgren
Leif Gustav Lindholm
Lars Torvald Svennerholm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Roland Holmgren, Leif Gustav Lindholm, Lars Torvald Svennerholm filed Critical Jan Roland Holmgren
Priority to SE8404283A priority Critical patent/SE455445B/sv
Publication of SE8404283D0 publication Critical patent/SE8404283D0/sv
Priority to DE8585850256T priority patent/DE3585061D1/de
Priority to AT85850256T priority patent/ATE71225T1/de
Priority to EP85850256A priority patent/EP0173663B1/en
Priority to JP60186757A priority patent/JPH0690204B2/ja
Publication of SE8404283L publication Critical patent/SE8404283L/sv
Publication of SE455445B publication Critical patent/SE455445B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
SE8404283A 1984-08-28 1984-08-28 Antikroppar mot sialosyllaktotetraos (iv?723neuaclcose?714) och antikroppens resp antigenets anvendning vid tumordiagnostik SE455445B (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8404283A SE455445B (sv) 1984-08-28 1984-08-28 Antikroppar mot sialosyllaktotetraos (iv?723neuaclcose?714) och antikroppens resp antigenets anvendning vid tumordiagnostik
DE8585850256T DE3585061D1 (de) 1984-08-28 1985-08-06 Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnose- oder therapieverfahren bezueglich krebskrankheiten.
AT85850256T ATE71225T1 (de) 1984-08-28 1985-08-06 Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten.
EP85850256A EP0173663B1 (en) 1984-08-28 1985-08-06 The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases
JP60186757A JPH0690204B2 (ja) 1984-08-28 1985-08-27 腫瘍に関連した特殊な抗原シアロシルラクトテトラオースに特異的な抗体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8404283A SE455445B (sv) 1984-08-28 1984-08-28 Antikroppar mot sialosyllaktotetraos (iv?723neuaclcose?714) och antikroppens resp antigenets anvendning vid tumordiagnostik

Publications (3)

Publication Number Publication Date
SE8404283D0 SE8404283D0 (sv) 1984-08-28
SE8404283L true SE8404283L (sv) 1986-03-01
SE455445B SE455445B (sv) 1988-07-11

Family

ID=20356831

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404283A SE455445B (sv) 1984-08-28 1984-08-28 Antikroppar mot sialosyllaktotetraos (iv?723neuaclcose?714) och antikroppens resp antigenets anvendning vid tumordiagnostik

Country Status (5)

Country Link
EP (1) EP0173663B1 (sv)
JP (1) JPH0690204B2 (sv)
AT (1) ATE71225T1 (sv)
DE (1) DE3585061D1 (sv)
SE (1) SE455445B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287916A1 (en) * 1987-04-13 1988-10-26 Otsuka Pharmaceutical Co., Ltd. Immunoassay
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
EP0380084A3 (en) * 1989-01-27 1991-03-13 The Biomembrane Institute Method for the inhibition of cell-cell and cell substratum interactions by the blocking of carbohydrate-carbohydrate interactions
AU5178090A (en) * 1989-03-09 1990-10-09 Sendai Institute of Microbiology, The Monoclonal antibody, and assay method, reagent kit, search method and drug missile using said antibody
AU2002239721C1 (en) 2000-12-22 2008-04-24 Medlyte, Inc. Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid
US20080138334A1 (en) 2006-05-31 2008-06-12 Sabbadini Roger A Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same
US8796429B2 (en) 2006-05-31 2014-08-05 Lpath, Inc. Bioactive lipid derivatives, and methods of making and using same
US9274129B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
DK2087002T3 (da) 2006-10-27 2014-10-27 Lpath Inc Sammensætninger og fremgangsmåder til binding af sphingosin-1-phosphat
AU2007313822A1 (en) 2006-10-27 2008-05-08 Lpath, Inc. Compositions and methods for treating ocular diseases and conditions
US8361465B2 (en) 2007-10-26 2013-01-29 Lpath, Inc. Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
US8871202B2 (en) 2008-10-24 2014-10-28 Lpath, Inc. Prevention and treatment of pain using antibodies to sphingosine-1-phosphate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4471057A (en) * 1981-06-30 1984-09-11 The Wistar Institute Detection of colorectal carcinoma
EP0118365B1 (en) * 1983-03-04 1990-08-29 Health Research, Inc. Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy
US4569788A (en) * 1983-05-18 1986-02-11 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies against non small cell lung cancer

Also Published As

Publication number Publication date
SE8404283D0 (sv) 1984-08-28
EP0173663B1 (en) 1992-01-02
DE3585061D1 (de) 1992-02-13
ATE71225T1 (de) 1992-01-15
SE455445B (sv) 1988-07-11
EP0173663A2 (en) 1986-03-05
EP0173663A3 (en) 1987-10-07
JPS61116660A (ja) 1986-06-04
JPH0690204B2 (ja) 1994-11-14

Similar Documents

Publication Publication Date Title
FR2527443B1 (fr) Composition contenant de l'endotoxine raffinee et medicament la contenant
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
IT7968574A0 (it) Dispositivo di infusione impiantabile nel corpo del paziente
IT1130709B (it) Regolatore impiantabile per l'infusione di sostanze medicinali
IT8019118A0 (it) Apparecchio manuale per la cura o il trattamento dei denti.
DK678887A (da) Farmaceutiske praeparater
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
NO163435C (no) Pasientstol for roentgenundersoekelser.
NO881643L (no) Fremgangsmaate for fremstilling av hoeystabile mykgelatinkapsler for terapeutiske formaal.
IT8867427A0 (it) Strumento medico per la terapia di lesioni emorroidali
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
FI853389A0 (fi) Tumoerlaekemedel och foerfarande foer dess framstaellning.
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
SE8402702D0 (sv) Anvendning av ett specifikt tumorassocierat antigen i hapten, nemligen fukosylsialosylgangliotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
LV10391A (lv) Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai
NO168040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3'-demetoksyepipodofyllotoksin-glukosidderivater.
ES2081279T3 (es) Utilizacion de 15-desoxiespergualina como medicamento.
NO304518B1 (no) Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem
DK38986A (da) Medicinsk inhalationsapparat
DK681288D0 (da) Aenootropt terapeutisk laegemiddelae
IT1209508B (it) Nuovi medicinali per il trattamento di malattie cardiache.
FI903637A0 (fi) Diagnostiska analysfoerfarande och deras anvaendning foer bestaemning av kliniska tillstaond.
IT8148480A0 (it) Composizione terapeutica e sistema per il trattamento extracorporeo di sangue intero

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8404283-7

Format of ref document f/p: F

NUG Patent has lapsed